Henlius Bevacizumab Trials Results Get International Recognition

As Company Submits HLX04 For Approval In China

 
• By Akriti Seth
  
China Pharma
Henlius seeks approval for its bevacizumab biosimilar in China • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products